Skip to main content
Clinical Trials/CTRI/2023/08/057033
CTRI/2023/08/057033
Completed
Phase 3

An Assessment of Implant Stability and Bone Density using CGF and I-PRF in Sinus Augmentation Procedure - A Randomized Control Trial - NI

Dr Unnati Agarwal0 sites10 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Unnati Agarwal
Enrollment
10
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 29, 2023
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Unnati Agarwal

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients willing for voluntary participation \& have signed informed consent for the described procedure.
  • 2\.Patients having good physical and mental health and well\-formed or moderately formed residual alveolar ridge
  • 3\.Systemically healthy subjects.
  • 4\.Patients requiring Sinus augmentation prior to placement of implant.
  • 5\.Patients well motivated for implant therapy and maintaining good oral hygiene.
  • 6\.Patients requiring bilateral sinus lift

Exclusion Criteria

  • 1\.Immunocompromised patients.
  • 2\.Grafted site (previous or during implant placement).
  • 3\.Patients of chronic and aggressive periodontitis.
  • 4\.Flapless procedures.
  • 5\.Alcohol or drug abuse.
  • 6\.Psychologically compromised patients.
  • 7\.Patients with temporomandibular disorders, severe residual ridge resorption, orofacial tumors and gross facial deformity, mucositis, radiation therapy, parafunctional habit, etc.
  • 8\.Patients with active diseases of the implant bed (e.g., residual cysts)
  • 9\.Cancer Patients (ongoing chemotherapy)
  • 10\.Patients on steroid therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials